Deferred Tax Assets, Gross of ABVC BIOPHARMA, INC. from 30 Sep 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
ABVC BIOPHARMA, INC. quarterly Deferred Tax Assets, Gross in USD history and change rate from 30 Sep 2011 to 31 Dec 2025.
  • ABVC BIOPHARMA, INC. Deferred Tax Assets, Gross for the quarter ending 31 Dec 2025 was $7,356,615, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $7,356,615 +$965,979 +15% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $6,907,870 +$633,300 +10% 30 Sep 2025 10-Q/A 03 Mar 2026 2025 Q3
Q2 2025 $6,761,724 +$519,239 +8.3% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $6,584,028 +$331,246 +5.3% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $6,390,636 +$659,070 +11% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $6,274,570 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $6,242,485 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $6,252,782 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 $5,731,566 -$845,018 -13% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $6,576,584 +$5,594,672 +570% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $1,013,159 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q4 2021 $981,912 31 Dec 2021 10-Q 14 Nov 2022 2022 Q3
Q4 2015 $25,734 -$3,733,266 -99% 31 Dec 2015 10-Q 23 Feb 2016 2016 Q1
Q3 2015 $29,075 -$3,455,925 -99% 30 Sep 2015 10-K 27 Nov 2015 2015 FY
Q2 2015 $8,380 30 Jun 2015 10-Q 19 Aug 2015 2015 Q3
Q1 2015 $3,885,000 31 Mar 2015 10-Q 05 Jun 2015 2015 Q2
Q4 2014 $3,759,000 +$3,759,000 31 Dec 2014 10-Q 23 Feb 2016 2016 Q1
Q3 2014 $3,485,000 +$3,485,000 30 Sep 2014 10-K 27 Nov 2015 2015 FY
Q4 2013 $0 31 Dec 2013 10-Q 17 Apr 2015 2015 Q1
Q3 2013 $0 -$1,937,364 -100% 30 Sep 2013 10-K 17 Apr 2015 2014 FY
Q3 2012 $1,937,364 -$2,681,853 -58% 30 Sep 2012 10-K 16 Apr 2015 2013 FY
Q3 2011 $4,619,217 30 Sep 2011 10-K 15 Apr 2015 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.